Ketamine

TERMINATED · PHASE2 · Ketamine, Refractory Cancer Pain

The study was terminated early due to the principal investigator's transition to another institution.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.